Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Alzheimer’s disease (AD) is a neurodegenerative disorder representing the leading cause of dementia and is affecting nearly 44 million people worldwide. AD is characterized by a progressive decline in acetylcholine levels in the cholinergic systems, which results in severe memory loss and cognitive...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Amit, Pintus, Francesca, Di Petrillo, Amalia, Medda, Rosaria, Caria, Paola, Matos, Maria João, Viña, Dolores, Pieroni, Enrico, Delogu, Francesco, Era, Benedetta, Delogu, Giovanna L., Fais, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849682/
https://www.ncbi.nlm.nih.gov/pubmed/29535344
http://dx.doi.org/10.1038/s41598-018-22747-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849682/
https://www.ncbi.nlm.nih.gov/pubmed/29535344
http://dx.doi.org/10.1038/s41598-018-22747-2

Ejemplares similares